Who is sponsoring NCT04023474?

NCT04023474 is sponsored by University of Florida.

What drugs are being tested in NCT04023474?

Interventions in NCT04023474: Platelet Rich Fibrin (PRF) Application.

What condition does NCT04023474 study?

NCT04023474 studies Head and Neck Disorder, Free Flap.

Is NCT04023474 still recruiting?

NCT04023474 is currently completed. Last updated 30 September 2020.

Last reviewed 2020-09-30 · How we verify

NCT04023474

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Platelet-Rich Fibrin in the Healing of Regional and Free Flaps

Completed NA Last updated 30 September 2020

What this trial tests

NA trial testing Platelet Rich Fibrin (PRF) Application in Head and Neck Disorder in 3 participants. Completed in 10 September 2020.

Timeline

16 December 2019

Primary endpoint
10 September 2020

10 September 2020

Quick facts

Lead sponsor	University of Florida
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	3
Start date	16 December 2019
Primary completion	10 September 2020
Estimated completion	10 September 2020
Sites	1 location across United States

Drugs / interventions tested

Platelet Rich Fibrin (PRF) Application

Conditions studied

Head and Neck Disorder — all drugs for Head and Neck Disorder →
Free Flap — all drugs for Free Flap →

Sponsor

University of Florida

Who can join

Adults 18 to 100, any sex, with Head and Neck Disorder or Free Flap. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Determine if the use of platelet-rich fibrin (PRF) versus historical treatment methods improves the post-operative management of healing complications from flap donor sites.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Head and Neck Disorder

Currently open trials in the same condition.

NCT06676592 — A Study of the Use of 3D Technology to Guide Head and Neck Surgery · NA · recruiting

Other University of Florida trials

Trials by the same sponsor.

NCT03429413 — Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial · NA · not yet recruiting
NCT06127550 — taVNS for Letter Learning in Dyslexia · NA · suspended
NCT07507214 — Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athl · Phase 2, PHASE3 · not yet recruiting
NCT07492316 — RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB) · Phase 1 · not yet recruiting
NCT06670794 — Using Ecological Momentary Data to Inform a Web Intervention for Romantic Partners Concerned About Their Loved Ones' Dri · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04023474 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Florida
Last refreshed: 30 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04023474.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing